Capvizr

Mykare Secures $3.2 Million in Latest Pre-Seed Funding Round

Capvizr Staff · · 2 min read

Mykare secured $3.2 million in its latest Pre-Seed, adding another data point to the Healthcare & Life Sciences funding market.

Pre-Seed$3.2 millionHealthcare & Life Sciencesfrom US

Mykare Raises $3.2 million in Funding

Latest Funding Rounds T Tringbox Full Profile Sector N/A Total Funding $530.1 K+ Stage Seed I INFLUISH Full Profile Sector N/A Total Funding Undisclosed Stage Pre-Seed X Xtovia Full Profile Sector Ecommerce Total Funding $731.5 K+ Stage Pre-Seed EXPLORE MORE ExclusiveMykare HealthHealth TechIn-Clinic HealthcareSurgeryTelemedicine Note: We at Inc42 take our ethics very seriously.

Investors Behind the Funding

The round was backed by patient acquisition. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Mykare operates in Healthcare & Life Sciences. Mykare's financing adds to recent private-market activity.

Strategic Use of Funds

Enhance AI Capabilities

Looking Ahead

Mykare Closes Round At $3.2 Mn To Enhance AI Capabilities

Source reference: original announcement/article.

View Mykare's full profile and funding history on Capvizr →